Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q2 2020 · 10-Q
Revenue$26.00M$26.00M+31.8% vs Q2 2019 Net Income$4.14M$4.14M+986.6% vs Q2 2019 EPS Diluted$0.19$0.19+850.0% vs Q2 2019 Gross Profit$15,978,000+40.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flowderived$3,705,000+21.5% Free Cash Flowderived$3,554,000−43.5% Margins · derivedGross margin61.5%+3.9 pt vs Q2 2019
Operating margin17.3%+12.4 pt vs Q2 2019
Net margin15.9%+14.0 pt vs Q2 2019
ended Jun 30, 2020 · filed Aug 14, 2020 · 45 d after period end